Please use this identifier to cite or link to this item:
|Title:||ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.||Austin Authors:||Luk, Ian Y;Reehorst, Camilla M;Mariadason, John M||Affiliation:||Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
School of Cancer Medicine, La Trobe University, Bundoora, Victoria 3086, Australia
|Issue Date:||30-Aug-2018||metadata.dc.date:||2018-08-30||Publication information:||Molecules (Basel, Switzerland) 2018; 23(9): E2191||Abstract:||The epithelium-specific ETS (ESE) transcription factors (ELF3, ELF5, EHF and SPDEF) are defined by their highly conserved ETS DNA binding domain and predominant epithelial-specific expression profile. ESE transcription factors maintain normal cell homeostasis and differentiation of a number of epithelial tissues, and their genetic alteration and deregulated expression has been linked to the progression of several epithelial cancers. Herein we review the normal function of the ESE transcription factors, the mechanisms by which they are dysregulated in cancers, and the current evidence for their role in cancer progression. Finally, we discuss potential therapeutic strategies for targeting or reactivating these factors as a novel means of cancer treatment.||URI:||http://ahro.austin.org.au/austinjspui/handle/1/19599||DOI:||10.3390/molecules23092191||ORCID:||0000-0001-9123-7684||PubMed URL:||30200227||Type:||Journal Article||Subjects:||EHF
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 9, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.